Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
The multiple-dose pharmacokinetics and safety of ciprofloxacin, a new quinoline carboxylic acid derivative, were evaluated in normal volunteers. The drug was administered orally every 12 h during successive 7-day periods at doses of 250, 500, and 750 mg. Samples of serum, urine, and saliva obtained...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1984
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180005/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6517556/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.5.741 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
